Appeal No. 95-3268
Application 07/521,695
APPENDIX
5. A method for potentiating the activity of pST which comprises administering
to a vertebrate, non-human an effective growth enhancing amount of pST and an effective
pST-potentiating amount of one or more monoclonal antibodies which specifically bind
pST or an antigenic equivalent of pST, wherein the monoclonal antibodies are selected
from the group consisting of monoclonal antibodies designated PS-7.6 (ATCC HB
10416), PS-3.12 (ATCC HB 10415) and PS-8.3 (ATCC HB 10417).
23. A method for potentiating the activity of a somatotropin over prolonged
periods of time which comprises administering to a vertebrate, non-human an effective
growth enhancing amount of a somatotropin and an effective somatotropin-potentiating
amount of one or more antibodies which specifically bind said somatotropin or an
antigenic equivalent of said somatotropin, such that the weight of the vertebrate non-human
continues to exceed that of a vertebrate, non-human treated with the same amount of said
somatotropin alone over a given period of time.
1
Page: Previous 1 2 3 4 5 6 7 8 9 10 11 12
Last modified: November 3, 2007